Best Options Strategy for BMY
Looking for the best options strategy for Bristol Myers Squibb (BMY)? There is no single answer — the right play depends on your outlook, your risk tolerance and current implied volatility. Below, our free engine shows the highest-scoring defined-risk strategy on the live BMY option chain right now, and a simple map from your view on BMY to the strategy that fits it. Model any of them in the calculator before you trade.
About BMY
Bristol Myers Squibb (BMY) is a major company in pharmaceuticals. Options traders on BMY tend to watch drug sales, patent cliffs and the pipeline, since these can drive large moves in the share price.
BMY for options traders
Bristol Myers Squibb trades with a structurally low implied volatility baseline, typical of large-cap dividend payers with diversified pharmaceutical revenue. The stock is not quiet by accident: much of its income comes from established blockbusters in oncology, immunology, and cardiovascular medicine, producing predictable cash flows that keep baseline IV compressed. What can shatter that calm are binary catalysts — pivotal clinical trial readouts, FDA approval or rejection decisions, and patent-expiry headlines — any of which can produce outsized single-day moves and temporary IV spikes well above the norm for the pharma sector.
BMY's options market is sufficiently liquid at near-the-money strikes for traders to execute common strategies with reasonable bid-ask spreads, though open interest thins out noticeably in far-dated or deep out-of-the-money contracts. The persistently low IV makes the stock a natural fit for income-oriented approaches: shareholders routinely write covered calls to extract premium from a slow-moving dividend name, while short puts suit traders comfortable acquiring shares at a discount. Ahead of binary regulatory or clinical events, long straddles or strangles become relevant — the IV spike into the event combined with potential for a large directional move can justify the higher debit. Iron condors and defined-risk spreads work well in the quiet stretches between catalysts.
Today's top-scoring strategy for BMY
Our engine ranks defined-risk strategies on the live BMY chain by probability of profit and risk/reward, then surfaces the best-scoring one. It is an educational illustration, not advice.
| Action | Qty | Type | Strike | Premium |
|---|---|---|---|---|
| Buy | 1× | CALL | $65 | $2.00 |
| Sell | 1× | CALL | $70 | $0.22 |
Simulation
Forward simulation of 6,000 lognormal price paths to expiration — not a historical backtest.
Strategy analysis
Greeks vs price
Price × volatility (today)
| −30% | −15% | IV | +15% | +30% | |
|---|---|---|---|---|---|
| $82 | $322 | $322 | $322 | $322 | $321 |
| $79 | $322 | $322 | $321 | $319 | $315 |
| $76 | $321 | $318 | $312 | $304 | $295 |
| $73 | $299 | $285 | $269 | $254 | $240 |
| $69 | $181 | $166 | $154 | $144 | $135 |
| $66 | −$36 | −$24 | −$14 | −$6 | $1 |
| $63 | −$160 | −$148 | −$134 | −$121 | −$109 |
| $59 | −$178 | −$176 | −$173 | −$168 | −$162 |
| $56 | −$178 | −$178 | −$178 | −$177 | −$176 |
| $53 | −$178 | −$178 | −$178 | −$178 | −$178 |
| $49 | −$178 | −$178 | −$178 | −$178 | −$178 |
Illustrative example at BMY's latest available price, computed with the same engine as the tool. Live option fills and the real IV skew refresh during US market hours.
Implied volatility
BMY is currently trading with low implied volatility, which keeps its option premiums relatively cheap. On the options we scanned that was around 18% implied volatility, and higher implied volatility means richer premiums and wider expected moves.
Options on BMY currently price in about 18% implied volatility, versus roughly 29% the stock has actually realised over the past month. That makes options relatively cheap — an edge for strategies that buy premium, such as long calls, long puts and debit spreads.
Off that volatility, the options market is pricing a move of about ±$3.42 (±5%) in BMY by 2026-09-04 — a range of roughly $62.49 to $69.33. Strikes inside that band hold most of the premium and see most of the action.
Across strikes, downside puts on BMY trade at a higher implied volatility than upside calls — the market is paying up for crash protection. That skew favours selling put spreads or buying calls over symmetric trades.
BMY insider trading activity (SEC Form 4)
Open-market insider transactions at BMY over roughly the last six months, from SEC Form 4 filings. Open-market buys are the rarer, more telling signal — routine selling under pre-arranged plans is common, so read a net-selling figure with that in mind.
| Insider | Action | Shares | Value | Date |
|---|---|---|---|---|
| Elkins David V | Sell | 4,481 | $278K | 2026-04-01 |
| Elkins David V | Sell | 25,519 | $1.6M | 2026-04-01 |
Source: SEC Form 4 filings via Finnhub. Open-market purchases (P) and sales (S) only — grants, option exercises, gifts and tax withholding are excluded. Informational context, not investment advice.
Earnings & IV crush
BMY's next earnings report is due around October 29, 2026. Options that expire after it price in a binary move, so their implied volatility is elevated and usually collapses right after the announcement — an "IV crush". If your expiration falls before this date, the trade sidesteps the event.
Dividend and assignment risk
BMY pays a dividend of about 3.9% a year, so short or covered calls on it carry early-assignment risk around each ex-dividend date — in-the-money calls are most exposed just before the stock goes ex-dividend.
Key figures
- Market cap
- $133.7B
- Beta (vs market)
- 0.23
- 52-week range
- $42.52–$68.10 (91% up the range)
- Short interest
- 2.2% of float · 3.3 days to cover
How to choose an options strategy for BMY
Start with your outlook on BMY, then match it to a defined-risk structure. Here are the most common choices and when each makes sense:
Bullish
Buy a call for leverage with capped risk, or a bull call spread to lower the cost and breakeven when you have a target price.
Long Call → Bull Call Spread →Bearish
Buy a put to profit from a decline with defined risk, or a bear put spread to cheapen the trade when you expect a measured move down.
Long Put → Bear Put Spread →Neutral
Sell an iron condor to collect premium while BMY stays between two strikes, or write a covered call against shares you already own.
Iron Condor → Covered Call →⧉ Embed this free calculator on your site →
How we pick the best strategy
For each ticker we pull the live option chain, build every supported strategy around the at-the-money strikes, and score them on probability of profit, risk/reward and capital efficiency — favouring defined-risk structures where the maximum loss is known up front. Methodology →
Open BMY in the free calculator →
Frequently asked questions
What is the best options strategy for BMY?
It depends on your outlook. Bullish traders often use a long call or bull call spread on BMY; bearish traders a long put or bear put spread; neutral traders an iron condor or covered call. Our live scan above shows the current highest-scoring defined-risk play.
Are BMY options liquid enough to trade?
Bristol Myers Squibb (BMY) is among the most actively-traded US options, which usually means tight bid/ask spreads and plenty of strikes and expirations — though you should always check the open interest and spread on the exact contract.
How much money do I need to trade BMY options?
Buying a single BMY call or put can cost as little as the premium (often one to a few hundred dollars), while income strategies like a cash-secured put need enough capital to buy 100 shares if assigned.
Is this financial advice?
No. Everything here is educational and uses delayed, third-party data. It is not a recommendation to trade BMY or any security. Do your own research.
What does Bristol Myers Squibb do?
Bristol Myers Squibb (BMY) operates in the Drug Manufacturers - General industry. The "About Bristol Myers Squibb" section above gives a fuller picture of what the company does and how it earns money.
Does Bristol Myers Squibb pay a dividend?
Yes — Bristol Myers Squibb currently pays a dividend yielding about 3.9%. If you hold the shares (for example to write a covered call), the ex-dividend date can trigger early assignment, so check it beforehand.
When does Bristol Myers Squibb next report earnings?
Bristol Myers Squibb's next earnings are expected around October 29, 2026. Implied volatility usually climbs into the report and drops sharply afterwards (IV crush) — important for any options position held over the date.
Price trend
Tickers related to BMY
Comparing BMY with similar names can help you choose the best options strategy:
Company information
- Headquarters
- Route 206 & Province Line Road, Princeton, NJ, 08543, United States
- Industry
- Drug Manufacturers - General
- Employees
- 32,500
- CEO
- Dr. Christopher S. Boerner Ph.D.
- Phone
- 609 252 4621
- Website
- www.bms.com
- Investor relations
- www.bms.com/investors/Pages/home.aspx
Best Options Strategy by Ticker →
Educational use only. Quotes are delayed ~15 minutes and nothing here is financial advice. Options trading involves substantial risk of loss. Privacy · Terms.